Maimoena S. Guman

Hoofddorp, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers.

Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers.

Journal: Obesity surgery

Published: September 29, 2022

Adipose Tissue, Bile Acids, and Gut Microbiome Species Associated With Gallstones After Bariatric Surgery.

Adipose Tissue, Bile Acids, and Gut Microbiome Species Associated With Gallstones After Bariatric Surgery.

Journal: Journal of lipid research

Published: March 17, 2022

Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.

Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.

Journal: The British journal of surgery

Published: January 27, 2022

Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgery.

Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgery.

Journal: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Published: December 16, 2021

Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.

Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.

Journal: Obesity surgery

Published: December 03, 2021

Pancreatic exocrine insufficiency after bariatric surgery.

Pancreatic exocrine insufficiency after bariatric surgery.

Journal: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Published: August 23, 2021

Gallstone Formation Follows a Different Trajectory in Bariatric Patients Compared to Nonbariatric Patients.

Gallstone Formation Follows a Different Trajectory in Bariatric Patients Compared to Nonbariatric Patients.

Journal: Metabolites

Published: August 19, 2021

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.

Journal: The lancet. Gastroenterology & hepatology

Published: May 26, 2021

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).

Journal: Trials

Published: April 16, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026